Venous Thromboembolism Prophylaxis
Introduction to Venous Thromboembolism Prophylaxis
- Venous thromboembolism (VTE) is a significant risk for patients undergoing hip arthroplasty, with more than 50% of patients without thromboprophylaxis developing deep vein thrombosis (DVT) and subsequent pulmonary embolism (PE), which carries a mortality rate of up to 50% 1
- Pulmonary embolism is the third leading cause of death in trauma patients, and VTE rates appear to be more than four times higher when low molecular weight heparin (LMWH) is administered more than 72 hours after admission 1
Recommended Prophylaxis Agents
- The American College of Chest Physicians recommends Low Molecular Weight Heparin (LMWH) as the preferred agent for DVT prophylaxis in patients undergoing hip arthroplasty, with extended prophylaxis for up to 35 days after surgery to reduce symptomatic VTE, due to its superior efficacy and established safety profile 2, 3, 4, 5, 6, 7, 8
- The recommended dosage for LMWH is 30 mg subcutaneously twice daily, starting 12-24 hours after surgery, and continuing for 10-14 days minimum, with extension up to 35 days recommended 2, 7, 5, 9, 4
- For patients >65 years, consider enoxaparin 30 mg every 12 hours, and for patients >75 years, use fondaparinux with caution 9, 7, 5
- Enoxaparin 40 mg subcutaneously once daily is the appropriate dosage for a 75-year-old woman with hip fracture, according to the American College of Chest Physicians 4
Alternative Prophylaxis Agents
- Direct oral anticoagulants (DOACs) such as Apixaban, Dabigatran, and Rivaroxaban are alternative options for DVT prophylaxis, with specific dosages recommended, such as Apixaban 2.5 mg orally twice daily, Dabigatran 220 mg orally once daily, and Rivaroxaban 10 mg orally once daily, starting 6-10 hours after surgery 2, 5, 6, 8, 4
- Rivaroxaban 10 mg daily is approved for VTE prophylaxis in orthopedic surgery, but the American College of Chest Physicians guidelines prioritize LMWH as first-line therapy 4
- Vitamin K antagonists (VKA) such as adjusted-dose warfarin are also an option for DVT prophylaxis, but Warfarin is specifically not recommended for VTE prophylaxis in orthopedic surgery patients, as it requires monitoring, has a delayed onset of action, and has a higher risk of bleeding complications compared to LMWH, according to the American College of Chest Physicians 2, 4
- Mechanical prophylaxis with intermittent pneumatic compression devices (IPCD) is recommended for patients with high bleeding risk 2, 1, 9, 10
Prophylaxis Duration and Initiation
- Prophylaxis should be initiated 12-24 hours after surgery, and continue for a minimum of 10-14 days, with extension up to 35 days recommended, as per the American College of Chest Physicians guidelines 4
- Extended prophylaxis with LMWH provides additional reduction in symptomatic VTE with a similar safety profile, as the risk of VTE persists for up to 2 months after hip surgery 2, 3, 4, 5, 6, 7, 8
Special Considerations
- For patients with liver injury, LMWH can be started with close monitoring, and in patients with high risk of bleeding, mechanical prophylaxis should be started and LMWH added when the risk decreases 1, 9
- For morbidly obese patients (>150 kg), consider increasing the dose of Lovenox to 40 mg twice daily, as recommended by the American Urological Association 10
- Patients with severe renal insufficiency (CrCl <30 mL/min) or when LMWH is contraindicated, unfractionated heparin may be used, with consideration for reduced-dose LMWH 2, 4
Monitoring and Assessment
- Serial clinical evaluations (physical exams and laboratory tests) should be performed to detect changes in clinical status, and signs and symptoms of DVT (such as calf pain, swelling, and warmth) should be monitored 1, 9
- Regular assessment for signs and symptoms of DVT and monitoring for bleeding complications is necessary, as well as ensuring proper administration of mechanical prophylaxis if used 9, 5
- The patient's risk for VTE should be evaluated using established scoring systems, with hip fracture surgery placing patients in a high-risk category 5, 3
Guideline Recommendations
- The American College of Chest Physicians and other guideline societies support LMWH as the preferred agent for DVT prophylaxis in hip arthroplasty patients, with extended prophylaxis for up to 35 days, based on comprehensive evidence 2, 11, 3, 4, 5, 6, 7, 8
- The World Health Organization recommends starting thromboprophylaxis with low molecular weight heparin (LMWH) as soon as possible after trauma, with individualization of the risk-benefit balance in patients taking anticoagulants 1
- The American College of Chest Physicians (ACCP) and the American Academy of Orthopaedic Surgeons strongly recommend VTE prophylaxis in elderly hip fracture patients, with LMWH as the preferred first-line option 12, 5, 13
Medication Dosage and Frequency
| Medication | Dose | Frequency | Duration |
|---|---|---|---|
| Enoxaparin | 30 mg | Twice daily | 10-14 days, up to 35 days |
| Fondaparinux | 2.5 mg | Once daily | 5-9 days, up to 24 additional days |
| Rivaroxaban | 10 mg | Once daily | Starting 6-10 hours after surgery |
| Unfractionated heparin | 5000 U | Every 8 hours | Primarily when LMWH is contraindicated or in patients with severe renal insufficiency |